Predicting Chemo-Radiotherapy Sensitivity With Concordant Survival Benefit in Non-Small Cell Lung Cancer via Computed Tomography Derived Radiomic Features

BACKGROUND: To identify a computed tomography (CT) derived radiomic signature for the options of concurrent chemo-radiotherapy (CCR) in patients with non-small cell lung cancer (NSCLC). METHODS: A total of 226 patients with NSCLC receiving CCR were enrolled from public dataset, and allocated to disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yixin, Qi, Haitao, Wang, Chunni, Deng, Jiaxing, Tan, Yilong, Lin, Lin, Cui, Zhirou, Li, Jin, Qi, Lishuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256940/
https://www.ncbi.nlm.nih.gov/pubmed/35814422
http://dx.doi.org/10.3389/fonc.2022.832343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256940/
https://www.ncbi.nlm.nih.gov/pubmed/35814422
http://dx.doi.org/10.3389/fonc.2022.832343

Ejemplares similares